Concepedia

Rolf Baenteli

RB

Statistics

Publications

1

Citations

15

H-Index

1

Active since

2009

Affiliations

Novartis (Switzerland)(Current)

Rolf Baenteli is an author at Novartis (Switzerland) specializing in drug discovery, protein-ligand docking, and g protein-coupled chemokine receptors.

Publications per year

2009–2009

1

Publications

1

Special ergolines are highly selective, potent antagonists of the chemokine receptor CXCR3: Discovery, characterization and preliminary SAR of a promising lead

Gebhard Thoma, Rolf Baenteli, Ian Lewis et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 15 citations · Full text

, , +13

1–1 of 1